ID   H6ST1_HUMAN             Reviewed;         411 AA.
AC   O60243; B4DEP2; B4DJ29; Q53SL2; Q9BVI1;
DT   11-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 5.
DT   10-MAY-2017, entry version 126.
DE   RecName: Full=Heparan-sulfate 6-O-sulfotransferase 1;
DE            Short=HS6ST-1;
DE            EC=2.8.2.-;
GN   Name=HS6ST1; Synonyms=HS6ST;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=9535912; DOI=10.1074/jbc.273.15.9208;
RA   Habuchi H., Kobayashi M., Kimata K.;
RT   "Molecular characterization and expression of heparan-sulfate 6-
RT   sulfotransferase.";
RL   J. Biol. Chem. 273:9208-9213(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 171-411 (ISOFORM 1).
RC   TISSUE=Cerebellum, and Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, VARIANTS HH15 TRP-306; GLN-306; GLN-323; TRP-382 AND
RP   VAL-404, AND CHARACTERIZATION OF VARIANTS HH15 TRP-306; GLN-306;
RP   GLN-323; TRP-382 AND VAL-404.
RX   PubMed=21700882; DOI=10.1073/pnas.1102284108;
RA   Tornberg J., Sykiotis G.P., Keefe K., Plummer L., Hoang X., Hall J.E.,
RA   Quinton R., Seminara S.B., Hughes V., Van Vliet G., Van Uum S.,
RA   Crowley W.F., Habuchi H., Kimata K., Pitteloud N., Bulow H.E.;
RT   "Heparan sulfate 6-O-sulfotransferase 1, a gene involved in
RT   extracellular sugar modifications, is mutated in patients with
RT   idiopathic hypogonadotrophic hypogonadism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:11524-11529(2011).
RN   [6]
RP   VARIANTS HH15 SER-218; GLN-306 AND TRP-306.
RX   PubMed=25077900; DOI=10.1210/jc.2014-2110;
RA   Marcos S., Sarfati J., Leroy C., Fouveaut C., Parent P., Metz C.,
RA   Wolczynski S., Gerard M., Bieth E., Kurtz F., Verier-Mine O.,
RA   Perrin L., Archambeaud F., Cabrol S., Rodien P., Hove H., Prescott T.,
RA   Lacombe D., Christin-Maitre S., Touraine P., Hieronimus S.,
RA   Dewailly D., Young J., Pugeat M., Hardelin J.P., Dode C.;
RT   "The prevalence of CHD7 missense versus truncating mutations is higher
RT   in patients with Kallmann syndrome than in typical CHARGE patients.";
RL   J. Clin. Endocrinol. Metab. 99:E2138-2143(2014).
CC   -!- FUNCTION: 6-O-sulfation enzyme which catalyzes the transfer of
CC       sulfate from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to
CC       position 6 of the N-sulfoglucosamine residue (GlcNS) of heparan
CC       sulfate. Critical for normal neuronal development where it may
CC       play a role in neuron branching. May also play a role in limb
CC       development. May prefer iduronic acid.
CC       {ECO:0000269|PubMed:21700882}.
CC   -!- CATALYTIC ACTIVITY: 3'-phosphoadenylyl sulfate + [heparan
CC       sulfate]-glucosamine = adenosine 3',5'-bisphosphate + [heparan
CC       sulfate]-glucosamine 6-sulfate.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type II
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O60243-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60243-2; Sequence=VSP_037048, VSP_037049;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in fetal brain.
CC       {ECO:0000269|PubMed:9535912}.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- DISEASE: Hypogonadotropic hypogonadism 15 with or without anosmia
CC       (HH15) [MIM:614880]: A disorder characterized by absent or
CC       incomplete sexual maturation by the age of 18 years, in
CC       conjunction with low levels of circulating gonadotropins and
CC       testosterone and no other abnormalities of the hypothalamic-
CC       pituitary axis. In some cases, it is associated with non-
CC       reproductive phenotypes, such as anosmia, cleft palate, and
CC       sensorineural hearing loss. Anosmia or hyposmia is related to the
CC       absence or hypoplasia of the olfactory bulbs and tracts.
CC       Hypogonadism is due to deficiency in gonadotropin-releasing
CC       hormone and probably results from a failure of embryonic migration
CC       of gonadotropin-releasing hormone-synthesizing neurons. In the
CC       presence of anosmia, idiopathic hypogonadotropic hypogonadism is
CC       referred to as Kallmann syndrome, whereas in the presence of a
CC       normal sense of smell, it has been termed normosmic idiopathic
CC       hypogonadotropic hypogonadism (nIHH).
CC       {ECO:0000269|PubMed:21700882, ECO:0000269|PubMed:25077900}.
CC       Note=The disease is caused by mutations affecting distinct genetic
CC       loci, including the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the sulfotransferase 6 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAY14736.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA25760.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA25760.1; Type=Frameshift; Positions=5, 7; Evidence={ECO:0000305};
CC       Sequence=BAG57153.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB006179; BAA25760.1; ALT_SEQ; mRNA.
DR   EMBL; AK293724; BAG57153.1; ALT_INIT; mRNA.
DR   EMBL; AK295898; BAG58691.1; -; mRNA.
DR   EMBL; AC017079; AAY14736.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BC001196; AAH01196.1; -; mRNA.
DR   EMBL; BC096239; AAH96239.4; -; mRNA.
DR   EMBL; BC096240; AAH96240.4; -; mRNA.
DR   EMBL; BC099638; AAH99638.4; -; mRNA.
DR   EMBL; BC099639; AAH99639.4; -; mRNA.
DR   CCDS; CCDS42748.1; -. [O60243-1]
DR   RefSeq; NP_004798.3; NM_004807.2. [O60243-1]
DR   UniGene; Hs.512841; -.
DR   UniGene; Hs.715359; -.
DR   ProteinModelPortal; O60243; -.
DR   SMR; O60243; -.
DR   BioGrid; 114793; 9.
DR   IntAct; O60243; 2.
DR   STRING; 9606.ENSP00000259241; -.
DR   iPTMnet; O60243; -.
DR   PhosphoSitePlus; O60243; -.
DR   BioMuta; HS6ST1; -.
DR   EPD; O60243; -.
DR   MaxQB; O60243; -.
DR   PaxDb; O60243; -.
DR   PeptideAtlas; O60243; -.
DR   PRIDE; O60243; -.
DR   Ensembl; ENST00000259241; ENSP00000259241; ENSG00000136720. [O60243-1]
DR   GeneID; 9394; -.
DR   KEGG; hsa:9394; -.
DR   UCSC; uc002tpt.5; human. [O60243-1]
DR   CTD; 9394; -.
DR   DisGeNET; 9394; -.
DR   GeneCards; HS6ST1; -.
DR   HGNC; HGNC:5201; HS6ST1.
DR   HPA; HPA044586; -.
DR   MalaCards; HS6ST1; -.
DR   MIM; 604846; gene.
DR   MIM; 614880; phenotype.
DR   neXtProt; NX_O60243; -.
DR   OpenTargets; ENSG00000136720; -.
DR   Orphanet; 478; Kallmann syndrome.
DR   Orphanet; 432; Normosmic congenital hypogonadotropic hypogonadism.
DR   PharmGKB; PA35102; -.
DR   eggNOG; KOG3955; Eukaryota.
DR   eggNOG; ENOG410XSW4; LUCA.
DR   GeneTree; ENSGT00390000013468; -.
DR   HOGENOM; HOG000007772; -.
DR   HOVERGEN; HBG083012; -.
DR   InParanoid; O60243; -.
DR   KO; K02514; -.
DR   OMA; QNLRPDQ; -.
DR   OrthoDB; EOG091G08UD; -.
DR   PhylomeDB; O60243; -.
DR   TreeFam; TF312835; -.
DR   BioCyc; MetaCyc:ENSG00000136720-MONOMER; -.
DR   Reactome; R-HSA-2022928; HS-GAG biosynthesis.
DR   ChiTaRS; HS6ST1; human.
DR   GenomeRNAi; 9394; -.
DR   PRO; PR:O60243; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000136720; -.
DR   CleanEx; HS_HS6ST1; -.
DR   Genevisible; O60243; HS.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0017095; F:heparan sulfate 6-O-sulfotransferase activity; IBA:GO_Central.
DR   GO; GO:0008146; F:sulfotransferase activity; TAS:ProtInc.
DR   GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
DR   GO; GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome.
DR   GO; GO:0015015; P:heparan sulfate proteoglycan biosynthetic process, enzymatic modification; IBA:GO_Central.
DR   GO; GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl.
DR   GO; GO:0048286; P:lung alveolus development; IEA:Ensembl.
DR   GO; GO:0048666; P:neuron development; IMP:UniProtKB.
DR   InterPro; IPR010635; Heparan_SO4-6-sulfoTrfase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR005331; Sulfotransferase.
DR   PANTHER; PTHR12812; PTHR12812; 1.
DR   Pfam; PF03567; Sulfotransfer_2; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome;
KW   Disease mutation; Glycoprotein; Hypogonadotropic hypogonadism;
KW   Kallmann syndrome; Membrane; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    411       Heparan-sulfate 6-O-sulfotransferase 1.
FT                                /FTId=PRO_0000190801.
FT   TOPO_DOM     11     17       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     18     37       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     38    411       Lumenal. {ECO:0000255}.
FT   REGION       96    102       5'-phosphosulfate-binding. {ECO:0000255}.
FT   REGION      185    193       3'-phosphate binding. {ECO:0000255}.
FT   COILED      352    387       {ECO:0000255}.
FT   COMPBIAS      2      5       Poly-Arg.
FT   CARBOHYD    264    264       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    320    320       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    162       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_037048.
FT   VAR_SEQ     163    175       VLDRRDSAALRTP -> MFSWCLWPVVGES (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_037049.
FT   VARIANT     218    218       P -> S (in HH15; dbSNP:rs200268730).
FT                                {ECO:0000269|PubMed:25077900}.
FT                                /FTId=VAR_072980.
FT   VARIANT     306    306       R -> Q (in HH15; 15 to 30% reduction in
FT                                enzymatic activity compared to wild-type;
FT                                dbSNP:rs201307896).
FT                                {ECO:0000269|PubMed:21700882,
FT                                ECO:0000269|PubMed:25077900}.
FT                                /FTId=VAR_069283.
FT   VARIANT     306    306       R -> W (in HH15; with anosmia; results in
FT                                Kallmann syndrome in the presence of
FT                                FGFR1 mutation Gln-250; approximately 50%
FT                                reduction in enzymatic activity compared
FT                                to wild-type; dbSNP:rs780352591).
FT                                {ECO:0000269|PubMed:21700882,
FT                                ECO:0000269|PubMed:25077900}.
FT                                /FTId=VAR_069284.
FT   VARIANT     323    323       R -> Q (in HH15; approximately 30%
FT                                reduction in enzymatic activity compared
FT                                to wild-type when heparan sulfate is the
FT                                acceptor substrate; dbSNP:rs761325768).
FT                                {ECO:0000269|PubMed:21700882}.
FT                                /FTId=VAR_069285.
FT   VARIANT     382    382       R -> W (in HH15; with or without anosmia;
FT                                results in Kallmann syndrome in the
FT                                presence of NSMF mutation Ala-480; 25 to
FT                                35% reduction in enzymatic activity
FT                                compared to wild-type;
FT                                dbSNP:rs199538589).
FT                                {ECO:0000269|PubMed:21700882}.
FT                                /FTId=VAR_069286.
FT   VARIANT     404    404       M -> V (in HH15; with anosmia; 30 to 70%
FT                                reduction in enzymatic activity compared
FT                                to wild-type).
FT                                {ECO:0000269|PubMed:21700882}.
FT                                /FTId=VAR_069287.
FT   CONFLICT     55     55       D -> Y (in Ref. 1; BAA25760).
FT                                {ECO:0000305}.
FT   CONFLICT    191    191       Y -> C (in Ref. 2; BAG57153).
FT                                {ECO:0000305}.
FT   CONFLICT    255    255       A -> T (in Ref. 2; BAG57153).
FT                                {ECO:0000305}.
SQ   SEQUENCE   411 AA;  48226 MW;  FCBF7AFAF1F3325D CRC64;
     MRRRRAGGRT MVERASKFVL VVAGSVCFML ILYQYAGPGL SLGAPGGRAP PDDLDLFPTP
     DPHYEKKYYF PVRELERSLR FDMKGDDVIV FLHIQKTGGT TFGRHLVQNV RLEVPCDCRP
     GQKKCTCYRP NRRETWLFSR FSTGWSCGLH ADWTELTNCV PGVLDRRDSA ALRTPRKFYY
     ITLLRDPVSR YLSEWRHVQR GATWKTSLHM CDGRTPTPEE LPPCYEGTDW SGCTLQEFMD
     CPYNLANNRQ VRMLADLSLV GCYNLSFIPE GKRAQLLLES AKKNLRGMAF FGLTEFQRKT
     QYLFERTFNL KFIRPFMQYN STRAGGVEVD EDTIRRIEEL NDLDMQLYDY AKDLFQQRYQ
     YKRQLERREQ RLRSREERLL HRAKEALPRE DADEPGRVPT EDYMSHIIEK W
//
